Effect of Acid Reducing Agents on Capivasertib: Rabeprazole (gastric acid reducing agent) did not have a clinically meaningful effect on capivasertib pharmacokinetics. Effect of Capivasertib on CYP3A Substrates: Concomitant use of TRUQAP increased midazolam (CYP3A substrate) AUC by 1.8-fold on day 4 and by 1.2-fold on day 7.
side effects and may not be effective in all patients. In phase 3 clinical trials, capivasertib demonstrated convincing results, eventually
Capivasertib side effects nausea, vomiting, or diarrhea; abnormal blood tests; blisters or ulcers in your mouth, red or swollen gums
Truqap (capivasertib) is a prescription drug that's used to treat a certain type of breast cancer. Truqap can cause side effects that range
side effects. In the trial, adding capivasertib to fulvestrant hormone therapy doubled the median time to disease progression, from 3.6
(capivasertib) tablets. TRUQAP (capivasertib) tablets. WAINUA You may report side effects related to AstraZeneca products. This site is
Higher than the indicated dosing of capivasertib can increase risk of capivasertib adverse reactions, including diarrhoea. side effects. Your doctor may need
According to the published findings in The New England Journal of Medicine, the most common side effects with capivasertib and Faslodex were
What Are Side Effects Associated with Using Capivasertib? diarrhea increased random glucose cutaneous adverse reaction decreased
Comments